Crystal Research Associates' Blog

CVR Medical Corp.: Announces Canon to Showcase CVR Medical’s Carotid Stenotic Scan (CSS) at Medical Design & Manufacturing West (MD&M), Feb. 5-7

GeoVax Labs, Inc. (GOVX-OTC) Nominated for 2019 ViE Awards in Three categories

CVR Medical Corp.: Announces Completion of FDA Submission for CSS Device (CVM-TSX; CRRVF-OTCQB)

GeoVax Labs, Inc. (GOVX-OTC) Nominated for Buzz of BIO Contest - Please VOTE!!

November 2018 Update Issued on GeoVax Labs (GOVX-OTC)

GeoVax Labs, Inc. (GOVX-OTC) Announces Publication of HIV Vaccines Review

CVR Medical Corp.: Company Update (CVM-TSX; CRRVF-OTCQB)

GeoVax Labs, Inc. (GOVX-OTC) Reports Vaccine Development Progress

CVR Medical Enlists JD Lymon Group to Provide Reimbursement & Study Design Support

August 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

New Research Released on CVR Medical Corp. (CVM-TSX; CRRVF-OTCQB)

New Research Released on Precision Therapeutics Inc. (AIPT-NASDAQ)

March 2018 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency

New Research Released on ZapGo Ltd (closely held)

October 2017 Update Issued on GeoVax Labs, Inc. (GOVX-OTC)

NDA for Aeterna Zentaris' (AEZS) Macrilen™ Granted December 30, 2017 PDUFA Date

GeoVax Labs. (GOVX-OTC) Reports Promising Results for Lassa Fever Vaccine

New Research Released on GeoVax Labs, Inc. (GOVX-OTC)

May 2017 Update Released on Aeterna Zentaris (AEZS)

April 2017 Update Released on Aeterna Zentaris (AEZS)

New Research Released on Avivagen Inc. (VIV-TSX.V)

February 2017 Update Released on Aeterna Zentaris (AEZS)

MagneGas Signs Definitive Agreements for $2.65 Million Equipment Sale to German Company

Sir Gregory Winter Appointed as Interim Chair of Biosceptre Int'l

New Research Released on Hemispherx Biopharma $HEB

New Research Released on Ceapro Inc. $CZO

New Research Released on MagneGas Corp. $MNGA

September 2016 Update Released on Aeterna Zentaris (AEZS)

UPDATE: Four Recent Milestones for Diagnostics Company SpectraScience (SCIE)

Two New Slide Presentations: Ra Medical Systems and Biosceptre International

New Research Released on Ra Medical Systems, Inc.

New Research Released on Biosceptre Int'l Ltd.

Crystal Research Associates Featured by Small Cap Nation (Video)

ASCO and IMS Health: Trends in the Cancer Care Market

First Quarter 2016 Update on Catasys, Inc.

First Quarter 2016 Update on Aeterna Zentaris

Changes in the Mental Health Industry are Benefiting Patients, Providers, Insurers, and Investors

NEW RESEARCH: Quarterly Update Released on Aeterna Zentaris (AEZS)

Saleen Brand Opens First Showroom in China

Making the Most of Your Investor Presentation

New Research Released on Aperion Biologics, Inc.

Mega Mergers in Big Pharma: What's driving them?

Big Data Helping to Reinvent Healthcare

Positive Phase 2 Data in Prostate Cancer from Biopharma Company Aeterna Zentaris

New Slide Deck Available on Catasys, Inc.

New Research Released on Catasys, Inc. (CATS-OTC)

NEW RESEARCH: 48-page Report Available on Diagnostics Company SpectraScience (SCIE)

NEW RESEARCH: 12-page Quarterly Update on Aeterna Zentaris (AEZS-NASDAQ)

Journal of Drugs in Dermatology Publishes Phase 2 Data for New Acne Treatment

New Slide Deck Available on Specialty Biopharma Company, Aeterna Zentaris Inc.

Slide Deck Available on Clean Energy Company, Juhl Energy, Inc.

60-page Report on Newly Public Company XBiotech Inc. (XBIT-NASDAQ)

Aeterna Zentaris Finalizes Key Promotional Agreement with Merck’s EMD Serono, Inc.

Amarantus Receives Notice of Allowance for Patent Application on MANF

NEW RESEARCH: 52-page Report Available on Aeterna Zentaris Inc. (AEZS-NASDAQ)

NEW RESEARCH: 56-page Executive Informational Overview Released on Juhl Energy, Inc.

Boston Therapeutics Announces Q4 and FY 2014 Financial Results and Corporate Update

Boston Therapeutics Expands Sugardown® License to Japan; Chinese Trial to Start

Amarantus BioScience Publishes Positive Parkinson's Phase 2a Data in Brain Journal

Pressure BioSciences Announces First Sale of Barozyme™ HT48 and Accelerated Marketing

Boston Therapeutics Measures the Impact of sugardown® Taken Before Sodas

Amarantus Acquires Specialized Neuro-Diagnostics Company, DioGenix, Inc.

New Topical Cannabis Cream, TopiCanna, Hits the Market

New Video Clip: Jeff Kraws Talks Antibiotic Resistance Forecasts and Impacts

Chewable Pill to Help Treat Type 2 Diabetes Receives IND Approval

NEW RESEARCH: Quarterly Update Available on Truett-Hurst (THST)

Amarantus Announces Major Potential Acquisition and 2014 LymPro Test® Launch

Pressure BioSciences Reports a YTD Sales Increase of 45%

New Study Measures Impact of OTC Supplement to Reduce Glucose and Insulin After Drinking Soda

Saleen Preps for 2015 Mustang; Reports Q2 Financials

California Winemaker Truett-Hurst Reports 20% Increase in Sales for Q1 FY2015

Biotech Company Amarantus Provides Business Update/Q3 2014 Financial Results

Boston Therapeutics Announces North American Branding of sugardown®

17 Awards in 2014 (so far!) for Winemaker Truett-Hurst

New Method to Improve Drug Discovery and Design Hinges on PCT

Pressure BioSciences Partners With Powertech for Chinese Sales

The Market May Be Down, But Amarantus is Up on Its News

Senior Analyst & CEO Jeff Kraws Discusses Ebola Therapies and Vaccines

Study Data: Amarantus One Step Closer to a Q4 Launch of an Alzheimer's Blood Test

CardioComm Solutions (EKG) Becomes Approved Vendor to U.S. Government

WABC-TV (New York) Spotlights MetaStat's Technology in 30-Minute Special

Expanding Boston Therapeutics' Medical Advisory Board and Patentable Uses of BTI-320

Boston Therapeutics Ramps Up Sugardown®, Expands Board of Directors

CardioComm Solutions' Technology Tapped for Stroke Prevention Trial

NEW RESEARCH: Pressure BioSciences On the Move

At 1:00 PM ET TODAY, Truett-Hurst call and webcast for fiscal 2014 results

Boston Therapeutics Strengthens its Medical Advisory Board

Truett-Hurst to Launch Single-Serving Wine Beverages Through Kroger

Saleen Takes Orders for New 2015 Mustang (pictures & specs)

Boston Therapeutics Signs Agreement for Phase III Study of BTI-320

Total Wine & More Adding More Truett-Hurst Wines to Shelves

Amarantus BioScience Outlines Required Steps for Eltoprazine Trial

Clinical Trial Finds Link Between Xanax, Valium and Alzheimer's Disease

NEW RESEARCH: Amarantus Pursues Novel Blood Test for Alzheimer's and More

NEW RESEARCH: August 2014 Update on Boston Therapeutics (BTHE)

NEW Slide Presentation Released for Truett-Hurst, Inc. (THST-NASDAQ)

NEW RESEARCH: Truett-Hurst (THST-NASDAQ) Innovates the Wine Industry

Dial-in Info for Investor Conference Call with Pressure BioSciences, Inc. ($PBIO)

Are Speed and Performance the Future of Electric Vehicles? They are for Steve Saleen.

Pressure BioSciences (PBIO) to Consider Strategic Financing and Spin-off Options

NEW RESEARCH: 12-page Quarterly Update Available on Pressure BioSciences (PBIO)

NEW RESEARCH: Saleen Automotive Poised for Growth

NEW RESEARCH: 12-page Quarterly Update on Boston Therapeutics ($BTHE)

Boston Therapeutics $BTHE Announces Strategic Marketing Agreement for SUGARDOWN®

Boston Therapeutics (BTHE-OTC) Inks Agreement with Patheon for BTI-320

CEO Jeffrey Kraws Live Interview on Pharma M&A Activity with ARISE News

BTI320 Product Update from Boston Therapeutics, Inc. (BTHE-OTC)

NEW RESEARCH: Executive Informational Overview Released for MetaStat, Inc. (MTST-OTC)

Pressure BioSciences, Inc. (PBIO) Reports Fourth Quarter and Fiscal Year 2013 Financial Results

NEW RESEARCH: 60-Page Executive Informational Overview on Boston Therapeutics (BTHE) Just Added

Dial-in Info for Investor Conference Call with International Stem Cell ($ISCO)

CardioComm Solutions ($EKG) Receives Another Key FDA Medical Device Clearance

An Introduction to the Sample Preparation Life Science Research Market

NEW RESEARCH: Updated Executive Informational Overview for AtheroNova Inc. (AHRO)

New Video Available: Regenerative Medicine Panel at OneMedForum SF 2014

Regenerative Medicine "Extending Life and Limb" Workshop

We have an app and a brand new website!

NEW Quarterly Update Available for CardioComm Solutions (EKG-TSX.V)

Letter to Shareholders Details CardioComm Solutions' 2014 Milestones

ISCO Receives Award for its Metabolic Liver Disease Program

PBIO: Investor Call with Merriman Capital on Thurs., Dec. 12 at 4:30p

ISCO Announces Major Advance in iPS Stem Cell Technology

AtheroNova Announces Phase I Enrollment Complete for Clinical Trial of AHRO-001 in Treating Atherosclerosis

Local Corp.: Core IP and Growing Markets Could Mean Business

Record Revenue and More Products to Come from Pressure BioSciences

ISCO: Third Quarter 2013 Financials and Business Update

Crystal Research CEO Speaks With ABC News/Al Jazeera on JNJ Settlement

NEW RESEARCH: Innovations in Life Science Research with $PBIO

Trio Resources (TRII) Begins Automating Mineral Processing

T3 Motion Creates National Service Program for its Electric Vehicles

Neonode (NEON): Next-Gen Chip Release and New Markets Fuel Growth

CardioComm’s HeartCheck™ Proven Valuable in Large-Scale Study

ISCO: New Preclinical Data, Continued Progress for Parkinson's Program

AtheroNova Announces New Member of Clinical Advisory Board

"The Smart Money is Heading Outside the U.S." - CNBC

Is Pharma Forecasting No Longer to be Trusted? McKinsey & Co. says Yes.

LRAD's Acoustic Hailing Devices to Aid in N. Colorado Flood Relief Efforts

NEW RESEARCH: 12-page Quarterly Update on International Stem Cell

ISCO Teams Up with Duke for Clinical Research in Parkinson's Disease

CardioComm Partner to Promote Case Study on SMART Monitoring Services

FULL VIDEO (Reuters TV): Biotech Stocks To Watch and More

Jeff Kraws Talks Opportunities for Biotech Investors

Home is where the HeartCheck™ is: NEW RESEARCH on CardioComm Solutions

NEW RESEARCH: 72-page Report on International Stem Cell Corp. (ISCO)

Russian Biotech Sector is Good News for U.S. Companies

AtheroNova Initiates Phase I Trial of AHRO-001

Fund Managers Unplugged: Industry Veterans Predict Stock Performance

NEW RESEARCH: 52-page Report on Convoy Therapeutics, Inc.

Join us at the 4th Annual OneMedForum 2013 in New York: June 26-27

AtheroNova Reaches Major Milestone: Starts Phase I in June

Crystal Research Enters into Strategic Partnership with MZ Group

NEW RESEARCH: 60-page Report on Trio Resources, Inc. (TRII-OTC)

Earnings Season Highlights: LRAD Corp. (LRAD-NASDAQ)

Earnings Season Highlights: Neonode Inc. (NEON-NASDAQ)

MetaStat Focuses on Lead Product Opportunity and Bolstering Pipeline

AHRO Nears its Phase I Start with Appointment of Clinical Chair

April 2013 Quarterly Update and Business Review on AtheroNova (AHRO)

CEO Jeff Kraws Featured on Reuters' State of the Union Roundtable

NEW RESEARCH: Quarterly Update on AtheroNova Inc.

NEW INDUSTRY REPORT: Guide for Investing in Green Infrastructure

NEW RESEARCH: New Year, Expanding Markets for LRAD Corp.

New Research: Report on MetaStat, Inc. (MTST-OTC.BB)

Today, January 9, 2013 at 4 PM: "Fund Managers Unplugged"

"Special Session: Fund Managers Unplugged" at OneMedForum SF 2013

Happy Holidays from Crystal Research Associates

QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Prepares for Phase I Trials

All posts

Content not found

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

May 2023 (2)
March 2023 (2)
January 2023 (1)
December 2022 (1)
November 2022 (1)
September 2022 (1)
August 2022 (2)
June 2022 (1)
May 2022 (1)
April 2022 (1)
March 2022 (2)
January 2022 (1)
November 2021 (2)
October 2021 (1)
August 2021 (1)
May 2021 (1)
March 2021 (1)
February 2021 (1)
December 2020 (1)
November 2020 (1)
October 2020 (1)
July 2020 (1)
June 2020 (1)
April 2020 (1)
March 2020 (1)
July 2019 (1)
May 2019 (1)
March 2019 (1)
February 2019 (1)
January 2019 (2)
December 2018 (1)
November 2018 (1)
October 2018 (2)
September 2018 (1)
August 2018 (2)
July 2018 (2)
March 2018 (1)
November 2017 (2)
October 2017 (1)
July 2017 (2)
June 2017 (1)
May 2017 (1)
April 2017 (1)
March 2017 (1)
February 2017 (1)
January 2017 (1)
December 2016 (1)
November 2016 (3)
September 2016 (3)
August 2016 (1)
July 2016 (1)
June 2016 (2)
May 2016 (2)
April 2016 (2)
January 2016 (2)
November 2015 (2)
October 2015 (1)
September 2015 (3)
August 2015 (1)
July 2015 (1)
June 2015 (3)
May 2015 (3)
April 2015 (2)
March 2015 (2)
February 2015 (2)
January 2015 (2)
December 2014 (4)
November 2014 (7)
October 2014 (11)
September 2014 (10)
August 2014 (5)
June 2014 (4)
May 2014 (3)
April 2014 (3)
March 2014 (2)
February 2014 (2)
January 2014 (5)
December 2013 (5)
November 2013 (5)
October 2013 (8)
September 2013 (2)
August 2013 (6)
July 2013 (1)
June 2013 (4)
May 2013 (5)
April 2013 (3)
February 2013 (2)
January 2013 (5)
December 2012 (1)
October 2012 (6)
September 2012 (3)
August 2012 (6)
July 2012 (3)
June 2012 (4)
May 2012 (9)
April 2012 (2)
March 2012 (4)
February 2012 (3)
January 2012 (8)
November 2011 (2)
October 2011 (1)
August 2011 (1)
July 2011 (1)
June 2011 (3)
May 2011 (2)
April 2011 (2)
March 2011 (2)
February 2011 (4)
January 2011 (4)
December 2010 (4)
November 2010 (4)
October 2010 (7)

see all

Posts by Topic

Crystal Research Associates (45)
Newsworthy Events (30)
immunotherapy (30)
New Research (29)
geovax (26)
hemorragic fever (25)
malaria (25)
vaccines (25)
aids/hiv (19)
hbv (19)
zika (19)
covid19 (18)
coronovirus (16)
AtheroNova (14)
BTHE (14)
biotech (14)
AEZS (13)
Pressure BioSciences (13)
nanotechnology (12)
Amarantus (10)
cancer (10)
LRAD (9)
OneMedForum (9)
green infrastructure (9)
CardioComm Solutions (8)
Truett-Hurst (8)
built environment (8)
CEL-SCI (7)
ISCO (7)
Applied DNA Sciences (6)
MetaStat (6)
biopharmaceuticals (6)
covid-19 (6)
lassa (6)
lasv (6)
Army Research Lab (5)
Bioniche (5)
CRRVF-OTCQB (5)
CVM-TSX (5)
Canon U.S.A. (5)
Carotid Stenotic Scan (CSS) (5)
Cleveland Clinic (5)
ENTICES Study (5)
Henry Ford Hospital (5)
Neonode Inc. (5)
Saleen (5)
Thomas Jefferson University Hospital (5)
Unilife Corp. (5)
atherosclerosis (5)
carotid health (5)
catasys (5)
cerebral angiogram (5)
computed tomography angiography (CTA) (5)
cvr medical (5)
duplex Doppler ultrasound (DUS) (5)
ischemic stroke (5)
magnetic resonance angiography (MRA) (5)
medical technology company (5)
occlusion (5)
stenosis (5)
stroke (5)
transient ischemic attack (TIA) (5)
Advaxis (4)
T3 Motion (4)
monkeypox (4)
Authentidate (3)
Biosceptre (3)
GenSpera (3)
MedPro (3)
Neuralstem (3)
Pluristem Therapeutics (3)
Prefilled Syringe (3)
SARS-CoV-2 (3)
autoimmune (3)
biotechnology (3)
touch technology (3)
zForce (3)
AMBS (2)
Cannabis (2)
Document Capture Technologies (2)
Ebola (2)
Endocannabinoid System (ECS) (2)
FSD201 (2)
JUHL (2)
Local Corporation (2)
MS (2)
Macrilen (2)
Multikine (2)
Palmitolylethonalamide (PEA) (2)
Peregrine (2)
Ra Medical (2)
SpectraScience (2)
Targeted Therapies (2)
Trio Resources (2)
artificial intelligence (AI) (2)
bioxytran (2)
cervical dysplasia (2)
complex carbohydrate chemistry (2)
fsd (2)
fsd pharma (2)
galectin (2)
galectrin-3 (2)
glycovirology (2)
head and neck cancer (2)
human induced pluripotent stem cell (2)
infectious diseases (2)
inflammatory (2)
leaps (2)
medical cannabis (2)
multiple sclerosis (2)
neurodegenerative (2)
rheumatoid arthritis (2)
squamous cell carcinoma (2)
ultramicronized-PEA (2)
wordlogic predictive keyboard (2)
xbit (2)
ABC News (1)
ACT Biotech (1)
Adamis (1)
Al Jazeera (1)
Albany NanoTech Complex (1)
Antibody (1)
Aperion (1)
Augmented reality (1)
Aura Health Inc. (1)
Bellus Health (1)
Biologics (1)
BreastSentry (1)
Bridgelux (1)
C-Ion® (1)
COVID-19 testing (1)
CZO (1)
Cameco Corp (1)
Canntab Therapeutics Ltd (1)
Carbon-Ion™ (1)
Clarity Lab Solutions (1)
College of Nanoscale Science and Engineering (1)
ColonSentry (1)
Commercial Solutions of Insurance Agency (1)
Contract manufacturing organization (CMO) (1)
Contract research organization (CRO) (1)
Convoy Therapeutics (1)
Craig Dionne (1)
Creator Economy (1)
Customer relationship management (CRM) (1)
D-CHIP™ (1)
EMMA (1)
EarlyCDT®-Lung (1)
Electronic medical records (1)
Employee Benefit Solutions (1)
Enterprise resource planning (ERP) (1)
Equinox (1)
ExpressMD (1)
Fortman Insurance Agency (1)
Fourth Industrial Revolution (1)
GEN-1 (1)
GLG Pharma (1)
Gen 4 technology (1)
General Cannabis (1)
Geomega (1)
GreenSteel (1)
Gunnar Weikert (1)
HEB (1)
Helomics® Corporation (1)
Huge Shops (1)
Human monoclonal antibodies (1)
Humanized monoclonal antibodies (1)
Huntingtons Disease (1)
IL-12 (1)
IR App (1)
Immunoassay (1)
Immunogen (1)
Inscrybe (1)
Internet of Things (1)
James Hayward (1)
KIACTA (1)
L-glutamine (1)
Lacoste (1)
Leslie Ziegler (1)
MNGA (1)
MZ Group (1)
Marburg (1)
Mark Reddish (1)
Metaverse (1)
Monoclonal antibody (1)
NBA (1)
NVIV (1)
New York Senate Higher Education Committee (1)
Non-fungible tokens (1)
Novo Nordisk (1)
Oncology (1)
PPHM (1)
Parkinsons Disease (1)
Pharmascience (1)
Polyclonal antibody (1)
Prismic Pharmaceuticals (1)
Prostate Cancer (1)
Puget Sound Blood Center (1)
Puma (1)
REIT (1)
RELI (1)
Rare earth elements (1)
Reuters (1)
SG Blocks (1)
SGBX (1)
SSc (1)
STREAMWAY System (1)
Saas (1)
Sanitec (1)
SciCann Therapeutics (1)
SearchCore (1)
Sentinel Principle (1)
Skyline Medical (1)
Software-as-a-Service (1)
Soladigm (1)
Solar photovoltaic (1)
Solarvest BioEnergy Inc. (1)
Southwestern Montana Insurance Center (1)
StageZero Life Sciences (1)
Starbucks (1)
Sudan (1)
Synthetic Biologics (1)
Taco Bell (1)
TapImmune (1)
Tauriga (1)
The Referral Depot (1)
The Steve Harvey Show (1)
ThermoDox (1)
TumorGenesis (1)
U.S. Benefits Alliance (1)
Unicorn company (1)
University of Albany (1)
VIVIMIND (1)
Verizon (1)
Victory Square Technologies (1)
Virtual reality (1)
Web 3.0 (1)
Xbiotech (1)
Zap&Go (1)
ZapGo Ltd (1)
aipt (1)
batteries (1)
bioinformatics (1)
bipilar disorder (1)
blood-based diagnostics (1)
breast cancer (1)
cancer vaccine (1)
cannabidiol (1)
cannabigerol (1)
cannabinoids (1)
cargo modified modules (1)
celsion (1)
clean technology metals (1)
color logic (1)
cordless power tools (1)
diabetes (1)
digitalDNA™ (1)
diverticulosis (1)
eletric cars (1)
emmaus life sciences (1)
endari (1)
energy storage device (1)
enterprise software (1)
fibrotic (1)
gene therapy (1)
generic drugs (1)
genomic (1)
genprex (1)
global graphics (1)
green building (1)
green construction (1)
hardware (1)
hepatocellular cancer (1)
hpv (1)
hybrid software (1)
hybrid software group (1)
hysg (1)
ic3d (1)
infrared touchscreen (1)
inkjet printing (1)
insurance (1)
insurance agencies (1)
insurance carriers (1)
interleukin-12 (1)
junior mining (1)
laptop computers (1)
liquid biopsy (1)
magnegas (1)
major depressive disorder (MDD) (1)
medical fluid waste collection (1)
mineral exploration (1)
mobile phones (1)
modular construction (1)
multi-family properties (1)
myelin degradation (1)
non-small cell lung cancer (1)
original equipment manufacturers (1)
orphan diseases (1)
orphan drug (1)
ovarian cancer (1)
personalized medicine (1)
precision medicine (1)
precision oncology (1)
precision therapeutics (1)
primary liver cancer (1)
proprietary Gen 3 technology (1)
real estate (1)
reliance global group (1)
reliance global holdings (1)
shipping containers (1)
sickle cell crisis (1)
sickle cell disease (1)
small-cell lung cancer (1)
systemic sclerosis (1)
technology (1)
telemedicine (1)
 REQORSA (1)